128 related articles for article (PubMed ID: 9473249)
1. Inverse targeting of retroviral vectors: selective gene transfer in a mixed population of hematopoietic and nonhematopoietic cells.
Fielding AK; Maurice M; Morling FJ; Cosset FL; Russell SJ
Blood; 1998 Mar; 91(5):1802-9. PubMed ID: 9473249
[TBL] [Abstract][Full Text] [Related]
2. Retroviral vector targeting human cells via c-Kit-stem cell factor interaction.
Yajima T; Kanda T; Yoshiike K; Kitamura Y
Hum Gene Ther; 1998 Apr; 9(6):779-87. PubMed ID: 9581901
[TBL] [Abstract][Full Text] [Related]
3. Targeting of retroviral vectors through protease-substrate interactions.
Nilson BH; Morling FJ; Cosset FL; Russell SJ
Gene Ther; 1996 Apr; 3(4):280-6. PubMed ID: 8732159
[TBL] [Abstract][Full Text] [Related]
4. Growth factor displayed on the surface of retroviral particles without manipulation of envelope proteins is biologically active and can enhance transduction.
Chandrashekran A; Gordon MY; Darling D; Farzaneh F; Casimir C
J Gene Med; 2004 Nov; 6(11):1189-96. PubMed ID: 15468194
[TBL] [Abstract][Full Text] [Related]
5. Displaying epidermal growth factor on spleen necrosis virus-derived targeting vectors.
Merten CA; Engelstaedter M; Buchholz CJ; Cichutek K
Virology; 2003 Jan; 305(1):106-14. PubMed ID: 12504545
[TBL] [Abstract][Full Text] [Related]
6. A gene delivery system activatable by disease-associated matrix metalloproteinases.
Peng KW; Morling FJ; Cosset FL; Murphy G; Russell SJ
Hum Gene Ther; 1997 Apr; 8(6):729-38. PubMed ID: 9113512
[TBL] [Abstract][Full Text] [Related]
7. A hyperfusogenic gibbon ape leukemia envelope glycoprotein: targeting of a cytotoxic gene by ligand display.
Fielding AK; Chapel-Fernandes S; Chadwick MP; Bullough FJ; Cosset FL; Russell SJ
Hum Gene Ther; 2000 Apr; 11(6):817-26. PubMed ID: 10779159
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence-based selection of gene-corrected hematopoietic stem and progenitor cells from acid sphingomyelinase-deficient mice: implications for Niemann-Pick disease gene therapy and the development of improved stem cell gene transfer procedures.
Erlich S; Miranda SR; Visser JW; Dagan A; Gatt S; Schuchman EH
Blood; 1999 Jan; 93(1):80-6. PubMed ID: 9864149
[TBL] [Abstract][Full Text] [Related]
9. Amphotropic retroviral vectors displaying hepatocyte growth factor-envelope fusion proteins improve transduction efficiency of primary hepatocytes.
Nguyen TH; Pagès JC; Farge D; Briand P; Weber A
Hum Gene Ther; 1998 Nov; 9(17):2469-79. PubMed ID: 9853514
[TBL] [Abstract][Full Text] [Related]
10. Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors.
Peng KW; Pham L; Ye H; Zufferey R; Trono D; Cosset FL; Russell SJ
Gene Ther; 2001 Oct; 8(19):1456-63. PubMed ID: 11593358
[TBL] [Abstract][Full Text] [Related]
11. Stem cell factor, interleukin-3, and interleukin-6 promote retroviral-mediated gene transfer into murine hematopoietic stem cells.
Luskey BD; Rosenblatt M; Zsebo K; Williams DA
Blood; 1992 Jul; 80(2):396-402. PubMed ID: 1378319
[TBL] [Abstract][Full Text] [Related]
12. Cell-specific targeting with retroviral vectors.
Paillard F
Hum Gene Ther; 1998 Apr; 9(6):767-8. PubMed ID: 9581898
[No Abstract] [Full Text] [Related]
13. Targeted retroviral transduction of c-kit+ hematopoietic cells using novel ligand display technology.
Chandrashekran A; Gordon MY; Casimir C
Blood; 2004 Nov; 104(9):2697-703. PubMed ID: 15256424
[TBL] [Abstract][Full Text] [Related]
14. Soluble Kit receptor blocks stem cell factor bioactivity in vitro.
Dahlen DD; Lin NL; Liu YC; Broudy VC
Leuk Res; 2001 May; 25(5):413-21. PubMed ID: 11301110
[TBL] [Abstract][Full Text] [Related]
15. Targeting retrovirus to cancer cells expressing a mutant EGF receptor by insertion of a single chain antibody variable domain in the envelope glycoprotein receptor binding lobe.
Lorimer IA; Lavictoire SJ
J Immunol Methods; 2000 Apr; 237(1-2):147-57. PubMed ID: 10725459
[TBL] [Abstract][Full Text] [Related]
16. Increased gene transfer into human hematopoietic progenitor cells by extended in vitro exposure to a pseudotyped retroviral vector.
von Kalle C; Kiem HP; Goehle S; Darovsky B; Heimfeld S; Torok-Storb B; Storb R; Schuening FG
Blood; 1994 Nov; 84(9):2890-7. PubMed ID: 7524756
[TBL] [Abstract][Full Text] [Related]
17. Delayed targeting of cytokine-nonresponsive human bone marrow CD34(+) cells with retrovirus-mediated gene transfer enhances transduction efficiency and long-term expression of transduced genes.
Veena P; Traycoff CM; Williams DA; McMahel J; Rice S; Cornetta K; Srour EF
Blood; 1998 May; 91(10):3693-701. PubMed ID: 9573006
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of c-kit and stem cell factor in breast cancer results in enhanced sensitivity to members of the EGF family of growth factors.
Hines SJ; Litz JS; Krystal GW
Breast Cancer Res Treat; 1999 Nov; 58(1):1-10. PubMed ID: 10634512
[TBL] [Abstract][Full Text] [Related]
19. A soluble CAR-SCF fusion protein improves adenoviral vector-mediated gene transfer to c-Kit-positive hematopoietic cells.
Itoh A; Okada T; Mizuguchi H; Hayakawa T; Mizukami H; Kume A; Takatoku M; Komatsu N; Hanazono Y; Ozawa K
J Gene Med; 2003 Nov; 5(11):929-40. PubMed ID: 14601130
[TBL] [Abstract][Full Text] [Related]
20. Chimeric ecotropic MLV envelope proteins that carry EGF receptor-specific ligands and the Pseudomonas exotoxin A translocation domain to target gene transfer to human cancer cells.
Erlwein O; Wels W; Schnierle BS
Virology; 2002 Oct; 302(2):333-41. PubMed ID: 12441077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
